Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Breast Neoplasms 66Rectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 8Triple Negative Breast Neoplasms 7Lung Neoplasms 6Adenocarcinoma of Lung 6Carcinoma, Intraductal, Noninfiltrating 5Breast Carcinoma In Situ 4Pancreatic Neoplasms 2Unilateral Breast Neoplasms 1Transsexualism 1Solitary Pulmonary Nodule 1Social Isolation 1Recurrence 1Piebaldism 1Patient Satisfaction 1Pain, Postoperative 1Neoplastic Cells, Circulating 1Neoplasm Micrometastasis 1Margins of Excision 1Lymphedema 1Local Recurrence of Malignant Tumor of Breast 1Inflammatory Breast Neoplasms 1Gynecomastia 1Gastrointestinal Stromal Tumors 1Chordoma 1Carcinoma, Lobular 1Carcinoma, Ductal, Breast 1Carcinoma, Ductal 1COVID-19 1

Interventions

Imatinib Mesylate 32regorafenib 9Sunitinib 9Laparoscopy 5Dasatinib 4Blood Specimen Collection 4pazopanib 3nilotinib 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Paclitaxel 3Observation 3spartalizumab 2ripretinib 2envafolimab 2binimetinib 2apatinib 2Temozolomide 2Neoadjuvant Therapy 2Ipilimumab 2Gemcitabine 2Docetaxel 2Cisplatin 2Carboplatin 2Capecitabine 2CTLA-4 Antigen 2Biopsy, Fine-Needle 2Biopsy 25-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 24-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Gastrointestinal Stromal Tumors × Mastectomy, Segmental × Clear all
NCT05970900 2023-08-01

PIRKER

Fujian Medical University Union Hospital

Phase 3 Not yet recruiting
23 enrolled
GastrointestinalSarcoma

Piebaldism, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡